Group items tagged

Persons who want to relocate to Spain have very good news in this sense, as Spain is the second country in the world offering the highest level of quality of life.

Explore Spain CME Conferences, Meetings, and Online CME Courses. Register for upcoming 2022 Spain Conferences & earn CME Credits.

When Ignasi Biosca-Reig heard there were shortages of amoxicillin in Spain, he quickly added shifts at his drug company's factories to boost production of the popular antibiotic. But a few extra shifts was as far as he could go. Much as he would have liked to significantly increase supplies, Biosca-Reig said he couldn't justify investing millions of euros in new production lines unless he was paid more for the generic drug to cover sharply rising costs. But, like many other European countries, Spain set the price manufacturers are paid for paediatric amoxicillin when the generic version of the drug was first launched in the country two decades ago, and it has barely budged since. "It's a non-business," said Biosca-Reig, chief executive of Spanish drugmaker Reig Jofre. "We wanted to react, but we had a problem," he said. "The costs go up, the price remains the same."

The history of surrogate motherhood goes back to biblical times. In fact, some people say it dates back to Sarah and Abraham. Certain people say that it started even before them, and that it is only recorded about Abraham because he was written about in the Bible. In many countries, surrogacy has been around since before records. Many cultures have belief systems that abide with the rules of surrogacy and those that do not agree can be thrown out of their families. Numerous religions and civilizations will actually celebrate the surrogate mothers, for their good deeds and service to others. During the 1980's surrogate mothers were used by the gay community to build their families, then, it was frowned upon by society. The American Indians were the first ones to truly begin the surrogate mother history in this part of the world. So we are looking back to the 1899's for the beginning of this part of the story. If an Indian woman was found to be infertile, then her husband would go to the chief of his tribe and ask for help. He would then be sent to see the medicine man, who would give the wife certain herbal concoctions. Then, after the witch doctor said nothing could be done to help his wife, the husband would go to see the chief. He would be allowed to take another woman and make her pregnant, hopefully, so that he would be able to father a son to carry on his tribe. The barren wife would have no relations with the child. He would stay with his birth mother. The American Indians were not the only civilization to use surrogate mothers to carry on the family name and bloodline. Back in recent European history it has been heard of, especially in Spain for kings to take in several surrogate mothers until he was born a son. The surrogate mother of the child would then become nanny to all of the royal children. The children would believe themselves to be genetically related to the king and queen. Never knowing the truth. Obviously, things like this were kept secret, bec

Surrogate motherhood history dates back to biblical times, some say it all started with Sarah and Abraham, others say it was around even before them, just they were the only ones recorded about it because of Abraham being in the bible. In countries all over the world the history of surrogate mothers dates back further than we can recall. Many cultures beliefs include surrogacy as a way of life, and those who don't abide by it are banned from their families. Many religions and cultures today believe the surrogates themselves are martyrs for their beliefs; their good deeds and overall intentions go unnoticed by many. In the 1980's the gay community took on the use of surrogates to form families for themselves; which was frowned upon then. If you really look at the history of surrogacy, aside from biblical times, it really began in the late 1800's with the Indians (which are just one culture.) If an Indian woman was found to be baron, the husband would go to the chief and inform the chief of this problem. The chief would then advise the husband to counsel with the witch doctor/ medicine man. After several attempts with medicine if the woman was still found to be baron, the chief would allow for the husband to consort with another female who was baron so that the husband would have a son to carry on his tribe; surrogacy then was not in vitro, rather, the male would have to have relations with the other female… the wife would have no biological ties to the child. But the Indians were not the only culture to use surrogacy as a means to carry on the family name. It's been known about throughout Europe and Spain and other such places. Kings would often bring in several surrogates until one bore him a son, then the surrogates would be kept as nannies to the child; the child would believe the King and Queen were its biological parents and know nothing about its genetic ties to the nanny. Often things of this matter were kept in close regard because if such thing

ImmunoGen has presented full data from the Phase III Forward I study of mirvetuximab soravtansine in ovarian cancer at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain, saying that it failed to meet the primary endpoint of progression-free survival (PFS).

Thornton & Ross is all set to expand its consumer healthcare offering by acquiring the well-established Opticrom eye-drops brand from Sanofi in the UK. Opticrom forms part of a wider transaction between Thornton & Ross' parent group, STADA, and Sanofi for eight local consumer healthcare brands across several countries, including Belgium, Germany, Hungary, Spain and the UK. The transaction will be financed with a combination of cash on balance sheet and existing facilities, and is scheduled to close in the fourth quarter of 2023, subject to customary approvals of relevant regulatory authorities. Opticrom Allergy 10ml bottle and 20 single doses for itchy, watery, red and inflamed eyes can be found behind the pharmacy counter, while Opticrom Hayfever 10ml bottle is available to purchase via self-selection to soothe and relieve eye symptoms of hayfever. These non-prescription medicines contain 20 mg/1ml sodium cromoglicate (2.0% w/v) and offer relief within 2 minutes.

Pharmanovia, a global pharmaceutical company has announced increased targets to divert 40 per cent of its air shipments to sea in 2023, and 75 per cent by the end of 2028. It has made the pledge as it revealed the significant progress made towards achieving its ambitious science-backed ESG initiatives in its new Sustainability Report. Its industry-leading air-to-sea pilot scheme, which focused on its Spain-to-Australia freight route, cut an estimated 470,000kg in potential CO2 emissions in 2022 - reducing Scope 3 upstream transport emissions by 18 per cent. This initiative demonstrates Pharmanovia's role as an industry leader on carbon reduction and follows a recent report which stated just 16 of 500 pharmaceutical companies measured their entire Scope 3 emissions. The new Sustainability Report reveals that the Scope 2 emissions decreasing by 13 per cent in 2022, due to lower direct electricity demand within the office space. The company's packaging audit seeing a 52 per cent increase in the percentage of products packed with at least one fully recyclable component, up from 12% in 2021 to 64 per cent in 2022 Strong progress in an initiative which saw Pharmanovia set ESG goals all employees across its global offices as part of annual performance awards. Employees achieved a 98 per cent completion rate of the compliance training, including ESG modules

The International Pharmaceutical Federation (FIP) in a report of a meeting of an international insight board published on Friday (27 January) highlighted the potential for pharmacists to close the existing gender gap in pain management. The insight board, assembled by FIP in Seville, Spain, in September 2022, was co-chaired by FIP vice president Professor Parisa Aslani. "Research indicates that pain experienced by women is underestimated and undertreated. Alarmingly, in addition to receiving less effective pain relief, evidence suggests that women with pain are more likely to be prescribed antidepressants," Prof. Aslani said. The insight board attributed much of this "gender pain gap" to implicit biases and put forward the view that pharmacy curricula and continuous professional development programmes must be able to provide adequate self-awareness and training to enable pain management without any bias. It also suggested ways in which pharmacists could be supported in addressing the gender pain gap in their practice.

Global consumer healthcare company Haleon has launched a new centre of excellence for a global leader in consumer health which will bring together world leading academics in human behaviour and frontline healthcare professionals including community pharmacists. Unveiled at the International Pharmaceutical Federation (FIP) Congress in 'sunny' Seville, Spain on September 20, the Centre will operate as a community of healthcare professionals and specialists in behavioural science, health psychology and the social sciences to solve some of the most pressing everyday health challenges. Named the Centre for Human Sciences (CHS) the initiative will be the first major programme for healthcare professionals since the Haleon's launch on July 18 as an independent, global leader in consumer health. The Centre's mission is to support practising health professionals - pharmacists, pharmacy assistants and dental professionals - in serving their patients and communities. Combining science with deep human understanding, CHS will bring expertise in physiology together with human sciences to deliver real world-solutions and tangible interventions, resulting in measurable improvements in health outcomes through sustained behavioural change. The Centre is facilitated by Robert Horne, professor of Behavioural Medicine at UCL School of Pharmacy, who started his career as a practising pharmacist but later chose to become a behavioural scientist when he saw an opportunity to address issues around psycho-social factors that acted as a hindrance in pharmacy practice. Speaking to me in an exclusive three-way conversation alongside Tess Player, the global head of healthcare professional & health influencer marketing at Haleon, on the sidelines of the FIP Congress 2022, Prof Horne expanded on what the Centre was all about and how it would work. "We've got some good ideas, but it's not a pre-filled prescription that we're going to deliver at scale from the start. What Haleon is t

Professional leadership bodies from around the world discussed workforce shortages in community pharmacy and other challenges affecting the sector at a global meeting held in Paris last month. Delegated from Denmark, Australia, Ireland, New Zealand, Portugal, Spain, US and the UK updated the conference on how the profession was progressing in practice, technology and workforce development in their respective countries. The UK was represented at World Pharmacy Council meeting by National Pharmacy Association chair Andrew Lane and chief executive at the Pharmaceutical Services Negotiating Committee Janet Morrison. Lane said: "It's very useful to be part of a global network of pharmacy bodies who are all going through similar challenges as we are in the UK. Sharing intelligence on other pharmacy systems around the world helps us to prepare the right strategy for engaging with the NHS at home. "Hearing some of the strides in services and digital technology in the profession gives us hope for the future of the sector. It's clear however that key challenges such as workforce shortages are starting to have an effect in other parts of the world too."

NHS England has secured a deal for 'Dexcom ONE Real Time-Continuous Glucose Monitoring' device which will help type 1 diabetes patients to keep track of their glucose levels at all times without having to scan or take a finger prick test. Once the patients receive their starter pack - which will include information on the product and usage, a sensor and transmitter - from the hospital or GP surgery, they can go to the community pharmacy for their repeat prescription. The wearable arm gadget sends information to a mobile app and allows diabetes patients to keep track of their glucose levels. "Traditionally, continuous glucose monitors are more expensive than their flash monitor counterparts - which record glucose levels by scanning a sensor - but thanks to the NHS agreeing on a new cost-effective deal with manufacturers DEXCOM, they will now be available for NHS patients on prescription at a similar price," said NHS. Dexcom ONE Real Time-Continuous Glucose Monitoring, uses a sensor no bigger than a bottle cap that attaches to the arm for up to 10 days and measures glucose levels from just under the skin. The wider rollout of the technology will help diabetes patients manage their condition better - reducing hospitalisations and associated diabetic illnesses which will ultimately ease pressure off the NHS. Karen Baxter, vice president, UK & Ireland, Benelux, France and Spain at Dexcom: "The addition of Dexcom ONE to the NHS England drug tariff is enormous progress towards improving the choice of diabetes tech, providing an alternative to burdensome finger pricks and scanning.